跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDE-TEVA CAPSULE 15mg - HSA Drug Approval Details
Approvals
/
HSA
/
LENALIDOMIDE-TEVA CAPSULE 15mg
Approved
THERAPEUTIC
LENALIDOMIDE-TEVA CAPSULE 15mg
PLIVA Croatia Ltd.
🇸🇬 Health Sciences Authority
Approval Date
May 17, 2024
Approval ID
5e4601c2dd1b6285
Company
PLIVA Croatia Ltd.
Type
Therapeutic
Approval Details
Approval Id
5e4601c2dd1b6285
Drug Name
LENALIDOMIDE-TEVA CAPSULE 15mg
Product Name
LENALIDOMIDE-TEVA CAPSULE 15mg
Approval Number
SIN17009P
Approval Date
2024-05-17
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
L04AX04
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Lenalidomide hydrochloride hydrate eqv. Lenalidomide
15 mg
Lenalidomide hydrochloride hydrate eqv. Lenalidomide
15 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 17, 2024
Approval ID
5e4601c2dd1b6285
Type
Therapeutic
Back to HSA Approvals